Company CVAbout Medicamen Biotech Ltd 
Medicamen Biotech Ltd
Micro Cap
Pharmaceuticals & Drugs
A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets. The Company has presence in 40+ countries. Its offerings include Finished Dosage Forms (FDF's) to African countries.
Company Coordinates
Company Details
1506 Chiranjiv Tower 43, Nehru Place New Delhi New Delhi : 110019
Registrar Details
Link Intime India Pvt Ltd., Narang Tower 44, Community Centre, Naraina Industrial Area , Phase - 1, New Delhi
Capital StructureCapital Structure
Present Equity Capital
INR 12.71 Cr
Number of Shares
1.27 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Feb-2024
1.27
12.71
63500
10
Conversion of Warrants
12-Sep-2022
1.27
12.65
434500
10
Preferential basis
21-May-2019
1.28
12.82
516600
10
Allotment of Equity To Others
21-May-2019
1.22
12.22
516600
10
Preferential basis
18-Apr-2018
1.17
11.70
324000
10
Preferential basis
06-Mar-2018
1.17
11.70
324000
10
Allotment of Equity To Others
01-Nov-2017
1.14
11.38
306000
10
Conversion of Warrants
01-Nov-2017
1.14
11.38
306000
10
Conversion of Warrants
12-Apr-2017
1.11
11.07
551394
10
Conversion of Warrants
12-Apr-2017
1.11
11.07
551394
10
Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 2 FIIs (0.05%)
Promoter with highest holding
Shivalik Rasayan Limited (42.99%)
Highest Public shareholder
Pharmadanica A/s (10.54%)
Individual Investors Holdings
32.96%
Board of Directors
Management
Designation
Remuneration
Sanjay Bansal
Director
0
Rahul Bishnoi
Chairman (Non-Executive)
0
Ashwani Kumar Sharma
Director
0
Harish Pande
Independent Director
0
S K Singh
Director
0
Arun Kumar
Independent Director
0
Parul Choudhary
Company Sec. & Compli. Officer
0
Sumita Dwivedi
Independent Director
0
Vimal Kumar Shrawat.
Director
0
Sangeeta Bishnoi
Independent Director
0
Ravi Kumar Bansal
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Formulations Products
111.69
100.00%
Pharmaceutical Formulations Products
Stock DNARevenue and Profits:
Net Sales:
45 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
Pharmaceuticals & Drugs
INR 635 Cr (Micro Cap)
75.00
33
0.20%
0.06
3.40%
2.90
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
